Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Choosing between SP 500 and multi-asset strategies depends on goals and risk comfort. This intro contrasts outcomes to guide retirement design.
26,826 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Peloton reports fresh restructuring amid a stubborn demand slump and rising costs. The destruction peloton continues ...
Mortgage purchase apps holding steady in 2026 despite rising rates, underscoring persistent demand in the housing mar...
Rocket Lab stands as the only public space stock with a direct line to actual launches and defense demand, even as Sp...
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...
Nvidia topped quarterly estimates with a sizable revenue beat and raised guidance, yet its stock slipped as traders w...
The trade desk stock swung sharply today as a major client questioned DSP usage. This piece breaks down what happened...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
Three mid-cap SaaS stocks are under renewed activist scrutiny as AI-fit strategies collide with balance-sheet pressur...
Jim Cramer says he is watching Marvell after Jensen Huang’s trillion-dollar endorsement, making the AI hardware name ...